MEPs vote for new public-private scheme for innovative medicines

Series Title
Series Details 27.01.14
Publication Date 27/01/2014
Content Type

The European Parliament's committee on industry, research and energy (ITRE) adopted on the 24 January 2014 the second public-private joint venture in innovative medicines (IMI2).

IMI is a public-private partnership between the European Commission and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
Source Link http://www.euractiv.com/health/meps-agree-new-iniative-innovati-news-533011
Related Links
ESO: Background information: EU Innovation Investment Package http://www.europeansources.info/record/speech-eu-innovation-investment-package/
Subject Categories
Countries / Regions